Select a news topic from the list below, then select a news article to read.

Immune testing for Coronavirus created by researchers in Västerbotten

Novel Coronavirus SARS CoV 2 NIH lr

[2020-04-15] Researchers at Umeå University and Norrland University Hospital have developed an antibody test for the new Corona virus

People who were once infected with the coronavirus also become immune to re-infection. By using tests that measure whether the body's immune system has reacted to the coronavirus, it is possible to identify people who are resistant to the infection. This is of particular importance for staff working in healthcare or working with risk groups, but also to determine so-called flock immunity, when enough people are immune to the spread of the virus.

On initiative of University Lecturer Mattias Forsell and through collaboration between researchers at Umeå University and the University Hospital in Umeå, a test has been developed in a short time, which could show immunity to coronavirus.

Read more: Immune testing for Coronavirus created by researchers in Västerbotten

Honory Doctor at the Faculty of Medicine

Iain Mattaj is one of the two honory doctors of the Faculty of Medicine in 2013

Iain Mattaj, Professor and Director General of EMBL (European Molecular Biology Laboratory), is the driving force behind the establishment of the Nordic EMBL Partnership for Molecular Medicine with MIMS as the Swedish partner.

playPress release Umeå University (in Swedish only)

Funding from the Swedish Foundation for Strategic Research


SSF grant to UCMR researchers for infection biology research 

Mikael Elofsson, Professor at Umeå University received 25 million SEK from the Swedish Foundation for Strategic Research. This funding will support an infection research project with the aim to identify novel, alternative antibiotics that have a decreased risk for the development of antibiotic resistance.

Co-operators in this project are Åke Forsberg, Professor at Umeå University and Herwig Schüler, group leader at the Karolinska Institutet.

 

playPress release Umeå University (in Swedish only)

Details of antibiotic resistance mechanisms revealed in hospital-acquired drug-resistant pathogens

Gemma Atkinson IMG 2401 562[2018-03-02] A new paper published by the research groups of Gemma Atkinson and Vasili Hauryliuk at Umeå University resolves years of uncertainty about how the widespread antibiotic resistance factors in the protein group ABCF family confer resistance to lincosamide antibiotics, often used in treatment of infections caused by staphylococci, streptococci and anaerobic bacteria.

Antibiotic resistance is one of the biggest threats to global health, food security, and development today and the new antimicrobial strategies are urgently needed. Scientists at the Umeå Centre for Microbial Research (UCMR) and at The Laboratory for Molecular Infection Medicine Sweden (MIMS) study therefore also antibacterial resistance mechanisms in order to develop new therapeutic strategies against resistant bacteria. The researchers solved recently a mystery in antibiotic resistance research and published their findings in the journal Nucleic Acids Research, which specialises in leading edge research into nucleic acids such as DNA and RNA, and the proteins with which they interact.

Read more: Details of antibiotic resistance mechanisms revealed in hospital-acquired drug-resistant pathogens